Code | 12320 | ||||||||||
MA number | 44/0033/13-S | ||||||||||
Product Form: | imp 1x10,8 mg (striek.inj.napl.) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | National | ||||||||||
MAH, country: | AstraZeneca AB, Sweden | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | pre-filled syringe | ||||||||||
Route of admin.: | Subcutaneous use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 15.04.1992 |
Pediatric contraindication: | Yes |
Pediatric warnings: | Yes |
SPC: |
|
PIL: |
|
Safety feature | Yes |
Data update: | 06.02.2018 |